Eric Joseph Daniels - Net Worth and Insider Trading

Eric Joseph Daniels Net Worth

The estimated net worth of Eric Joseph Daniels is at least $38,772 dollars as of 2024-10-06. Eric Joseph Daniels is the Chief Development Officer of Kiora Pharmaceuticals Inc and owns about 11,222 shares of Kiora Pharmaceuticals Inc (KPRX) stock worth over $38,772. Details can be seen in Eric Joseph Daniels's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Joseph Daniels has not made any transactions after 2024-06-14 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Eric Joseph Daniels

To

Eric Joseph Daniels Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Eric Joseph Daniels owns 1 companies in total, including Kiora Pharmaceuticals Inc (KPRX) .

Click here to see the complete history of Eric Joseph Daniels’s form 4 insider trades.

Insider Ownership Summary of Eric Joseph Daniels

Ticker Comapny Transaction Date Type of Owner
KPRX Kiora Pharmaceuticals Inc 2024-06-14 Chief Development Officer

Eric Joseph Daniels Latest Holdings Summary

Eric Joseph Daniels currently owns a total of 1 stock. Eric Joseph Daniels owns 11,222 shares of Kiora Pharmaceuticals Inc (KPRX) as of June 14, 2024, with a value of $38,772.

Latest Holdings of Eric Joseph Daniels

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
KPRX Kiora Pharmaceuticals Inc 2024-06-14 11,222 3.46 38,772

Holding Weightings of Eric Joseph Daniels


Eric Joseph Daniels Form 4 Trading Tracker

According to the SEC Form 4 filings, Eric Joseph Daniels has made a total of 1 transactions in Kiora Pharmaceuticals Inc (KPRX) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Kiora Pharmaceuticals Inc is the acquisition of 1,431 shares on June 14, 2024, which cost Eric Joseph Daniels around $7,570.

Insider Trading History of Eric Joseph Daniels

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Eric Joseph Daniels Trading Performance

GuruFocus tracks the stock performance after each of Eric Joseph Daniels's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Joseph Daniels is -31.72%. GuruFocus also compares Eric Joseph Daniels's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Joseph Daniels within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Eric Joseph Daniels's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Eric Joseph Daniels

Average Return

No transaction record over 1 Year.

Outperforming Transactions

No transaction record over 1 Year.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -21.08 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -24.46 LIMIT LIMIT LIMIT LIMIT LIMIT

Eric Joseph Daniels Ownership Network

Ownership Network List of Eric Joseph Daniels

No Data

Ownership Network Relation of Eric Joseph Daniels

Insider Network Chart

Eric Joseph Daniels Owned Company Details

What does Kiora Pharmaceuticals Inc do?

Who are the key executives at Kiora Pharmaceuticals Inc?

Eric Joseph Daniels is the Chief Development Officer of Kiora Pharmaceuticals Inc. Other key executives at Kiora Pharmaceuticals Inc include EVP of Finance Melissa Tosca , director & President and CEO Brian M. Strem , and Interim CFO Susan L. Drexler .

Kiora Pharmaceuticals Inc (KPRX) Insider Trades Summary

Over the past 18 months, Eric Joseph Daniels made 1 insider transaction in Kiora Pharmaceuticals Inc (KPRX) with a net purchase of 1,431. Other recent insider transactions involving Kiora Pharmaceuticals Inc (KPRX) include a net purchase of 2,100 shares made by Melissa Tosca , a net purchase of 5,260 shares made by Erin Parsons , and a net purchase of 5,000 shares made by Praveen Tyle .

In summary, during the past 3 months, insiders sold 0 shares of Kiora Pharmaceuticals Inc (KPRX) in total and bought 12,500 shares, with a net purchase of 12,500 shares. During the past 18 months, 0 shares of Kiora Pharmaceuticals Inc (KPRX) were sold and 22,291 shares were bought by its insiders, resulting in a net purchase of 22,291 shares.

Kiora Pharmaceuticals Inc (KPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Kiora Pharmaceuticals Inc Insider Transactions

No Available Data

Eric Joseph Daniels Mailing Address

Above is the net worth, insider trading, and ownership report for Eric Joseph Daniels. You might contact Eric Joseph Daniels via mailing address: C/o Eyegate Pharmaceuticals Inc., 271 Waverly Oaks Rd., Ste 108, Waltham Ma 02452.

Discussions on Eric Joseph Daniels

No discussions yet.